about
Variation of breast cancer risk among BRCA1/2 carriers.Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing genePotential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibilityPredicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.Association of common ATM variants with familial breast cancer in a South American population.The UPS: a promising target for breast cancer treatment.Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.Hemizygosity for Atm and Brca1 influence the balance between cell transformation and apoptosis.Cancer and neurodegeneration: between the devil and the deep blue sea.Multicenter breast cancer collaborative registry.Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.The association between ATM IVS 22-77 T>C and cancer risk: a meta-analysis.Breast cancer susceptibility: current knowledge and implications for genetic counsellingGenome-wide small RNA sequencing and gene expression analysis reveals a microRNA profile of cancer susceptibility in ATM-deficient human mammary epithelial cells.Association of the ATM gene polymorphisms with papillary thyroid cancer.ATM gene mutations in sporadic breast cancer patients from Brazil.Methylation of tumor suppressor genes is related with copy number aberrations in breast cancerA minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activityGenetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome.Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer.Changes of Ovarian microRNA Profile in Long-Living Ames Dwarf Mice during AgingIdentification, genetic testing, and management of hereditary melanoma.Multiple isoforms of CDC25 oppose ATM activity to maintain cell proliferation during vertebrate development.Hereditary diffuse gastric cancer: association with lobular breast cancer.Models of genetic susceptibility to breast cancer.Recent progress in mouse models for tumor suppressor genes and its implications in human cancer.Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.Syndrome-Associated Tumors by Organ System.Genetic predispositions to childhood leukemia.Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitorsGenetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.Gene expression signatures but not cell cycle checkpoint functions distinguish AT carriers from normal individualsGenomic Biomarkers for Breast Cancer Risk.Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage.Tumor protein D52 represents a negative regulator of ATM protein levels.New arylated benzo[h]quinolines induce anti-cancer activity by oxidative stress-mediated DNA damage.DNA Repair Gene Expression Levels as Indicators of Breast Cancer in the Breast Cancer Family Registry.Caspases and cancer.
P2860
Q24646346-8207A5DC-91E1-4B2C-A2A4-8E53294DE0F5Q28242019-E3B01198-C6F3-4EEA-87DC-08332DF3AB17Q28943457-96F9900C-E708-44A5-B7AF-D14510739D1FQ30966966-7B81FC36-733C-48C1-9DE8-EAD2CEE62D32Q33330505-32B96A72-C15A-470A-9D37-EC1B73F220CAQ33384289-9BF02C0D-DEF9-40E7-8B82-08DD9A1C5BD7Q33703779-76AD5ACB-8879-44C5-A2D6-81E1ACB086F0Q33711869-C0845544-3E7A-4648-9AD1-C7AD4F741CF8Q33784620-16A723C1-9FF6-4954-B14A-203FA0F52E62Q34019748-D4F0DEF7-C163-44B5-AEF1-BCFE4CD74A04Q34123806-691B2EBE-BDA0-4077-8C39-2E8B9E7D7AA3Q34140207-1A7776B3-2E4E-434B-83C1-0EDE6D4CF740Q34161642-AF3ECE5F-CC64-4816-B328-69A94BC77177Q34760829-7BC00724-882E-48A3-B178-7C0E6324DB7AQ34909764-47EF018C-81BE-4DD3-82F4-A6096035404FQ34983335-C762CCC1-40AC-4469-B650-BD87F6B2D89DQ34991280-F4F28F80-E6DE-40CD-A7CC-03A579A99613Q35002385-41BB126F-4972-4B9A-BB99-BFD81A308A2DQ35043093-5E28D971-8343-4870-90F6-6260360506EBQ35843205-325DC842-F7AA-4283-9F58-7BDFEE1DBC17Q36063685-14C66BFB-C893-4226-85BC-94D4BB09C0AEQ36238604-6ABB3569-66A6-4DF2-8E6C-84080D9920B7Q36304955-C322DAE3-A339-4248-A71A-CF6881F3A590Q36438934-88FC17B9-1D86-4487-8DAE-82D6F0B062D3Q36477282-78B28865-C34E-4E52-9066-AAF3D5279448Q36602581-1B83B3F8-5898-426C-B8F1-F2A80C3015CDQ36929407-530897AB-BC94-4BE7-AFFC-AC4FF8C0233CQ37005060-3A8C4E78-D561-418B-B452-C21D9BEC6C8AQ37018223-A90E95AE-E892-4AEA-8D91-91E79FF5AFDBQ37032662-D7A85A94-5F05-4A60-B4F0-9A8C2E2A18BBQ37073895-BC7C93D8-546C-4C96-B916-7D85FD949EBDQ37119667-5FF61622-490F-469D-9999-831566B3CFD3Q37196316-08A82264-D550-42F4-82D5-98D36524C8DCQ37234933-6033B814-ED6C-4FDC-94DC-A96ED412CEAEQ37242239-7D218F1C-85DA-4060-A032-45362AEF1DBFQ37308888-E148740B-D43B-44F3-B4DF-FBF1440589E1Q37420061-07802906-7611-411A-973E-2B548FA9D8CDQ37475968-965A99D1-1AE3-4CDB-BC4F-C1CA237A7A4AQ37612657-CA205337-5A0C-48C4-A41B-7F91D7689084Q37860139-8E5E6710-85BC-49AA-BC81-563EADD6C180
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
ATM and breast cancer susceptibility.
@ast
ATM and breast cancer susceptibility.
@en
ATM and breast cancer susceptibility.
@nl
type
label
ATM and breast cancer susceptibility.
@ast
ATM and breast cancer susceptibility.
@en
ATM and breast cancer susceptibility.
@nl
prefLabel
ATM and breast cancer susceptibility.
@ast
ATM and breast cancer susceptibility.
@en
ATM and breast cancer susceptibility.
@nl
P2860
P356
P1433
P1476
ATM and breast cancer susceptibility.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209873
P407
P577
2006-09-01T00:00:00Z
P5875
P6179
1041078054